Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Bragnum Invest with their acquisition of SkySparc
Mandate

Vinge has advised Bragnum Invest with their acquisition of SkySparc

July 08, 2019 M&A

Vinge has advised Bragnum Invest with their acquisition of SkySparc, an independent solutions provider trusted by banks, central banks, Fortune 100 corporate treasuries and asset managers and offers complementary software, outsourced support and a wide range of financial and technical consulting services.

The core team consisted of Christina Kokko, project leaders Hedvig Ekdahl and Christina Odengran, Ulrich Ziche, Lisa Ullman, Sarah Berger, Agnes Perbo, Christopher Widström, Ilze Lukins and Victoria Owetz.

Existing SkySparc owners and staff will remain significant shareholders in the company.
 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026